Talis Biomedical Corporat... (TLIS)
1.57
0.00 (0.00%)
At close: Jan 24, 2025, 3:56 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -62.01M | -113.01M | -192.04M | -91.13M | -27.47M | -21.34M |
| Depreciation & Amortization | 770.00K | 8.83M | 1.58M | 763.00K | 726.00K | 647.00K |
| Stock-Based Compensation | 4.35M | 5.37M | 9.21M | 3.68M | 965.00K | 679.00K |
| Other Working Capital | -1.25M | -6.37M | 8.61M | 91.00K | 455.00K | -1.53M |
| Other Non-Cash Items | 7.07M | 6.36M | 1.04M | 611.00K | 817.00K | 3.37M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -3.42M | -7.69M | 8.82M | -951.00K | 640.00K | -932.00K |
| Operating Cash Flow | -53.24M | -100.14M | -171.38M | -87.02M | -24.33M | -20.94M |
| Capital Expenditures | -486.00K | -1.61M | -2.87M | -8.20M | -578.00K | -533.00K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -486.00K | -1.61M | -2.87M | -8.20M | -578.00K | -533.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | 15.00M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 33.00K | 406.00K | 1.88M | 246.75M | 24.61M | 8.00K |
| Financial Cash Flow | 33.00K | 406.00K | 234.43M | 246.75M | 39.61M | 8.00K |
| Net Cash Flow | -53.69M | -101.34M | 60.18M | 151.53M | 14.71M | -21.47M |
| Free Cash Flow | -53.73M | -101.75M | -174.25M | -95.22M | -24.90M | -21.48M |